Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database

PURPOSE: Long-acting bronchodilator (LABD) use is the mainstay of pharmacologic treatment for chronic obstructive pulmonary disease (COPD). Few studies describe evolving patterns of LABD use in the setting of changing inhaler availability and updated clinical guidelines. METHODS: A retrospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Milea, Dominique, Yeo, See-Hwee, Nam, Yein, Navarro Rojas, Aldo Amador, Shantakumar, Sumitra, Beale, Janine, Marett, Brett, Young, Robert P, Scott, Raewyn J, Gribben, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068498/
https://www.ncbi.nlm.nih.gov/pubmed/33907394
http://dx.doi.org/10.2147/COPD.S290887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068498/
https://www.ncbi.nlm.nih.gov/pubmed/33907394
http://dx.doi.org/10.2147/COPD.S290887

Ejemplares similares